Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 7,308 shares at $31.61 ($231K) on 2022-12-22, disclosed to the SEC on 2022-12-23.
Open-market sale of $231k VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.61 | 3,654 | $116K | 50.0% |
| 2 | $31.61 | 3,654 | $116K | 50.0% |
| Total | $31.61 avg | 7,308 | $231K | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |